Market
Scenario
The
global legg-calve-Perthes disease treatment market is expected to register a
significant growth during the forecast period (2018–2023).
Legg-calve-perthes
is a disease which occurs when the blood supply to the femoral head (upper end
of the thigh bone) which fits in the hip socket temporarily stops to flow. As
an outcome, the femoral head is no longer round and does not move smoothly in
the hip socket, resulting in hip pain and constrained leg movements.
Legg-calve-perthes
disease (LCPD) generally occurs in children of age 4 to 10 years. Individuals
suffering from the disease go on developing a painful joint disorder called as
osteoarthritis in the hips at an early age. Individuals suffering from the
legg-calve-Perthes disease are often short compared to healthy individuals due
to bone anomalies.
Major factors such as rising frequency rate in
Perthes disease and increasing awareness about the Perthes disease boosts the
market rate exponentially. Furthermore, the advancement of technology such as
point-of-care drug delivery systems and focus on delivering good quality of
life are some of the factors contributing to the growth of the market. Not
identifying and treating the Perthes disease at initial stages are major
restrains for the growth of the market.
Segmentation
The
global legg-calve-Perthes disease treatment market has been segmented on the
basis of type, application, age group, and end-user.
On the
basis of type, the market has been classified as non-surgical and surgical
methods. The non-surgical method is segmented into anti-inflammatory
medications, casting and bracing, crutches, and others. casting and bracing is
further segmented into Newington brace, Toronto orthosis, Scottish rite
orthosis, broomstick plasters, and Birmingham orthosis. The others
segment is further segmented into conventional calipers, Snyder slings, slings
with crutches, and traction. The surgical method is segmented into femoral
osteotomy, innominate osteotomy, a combination of femoral osteotomy, and
innominate osteotomy.
On the
basis of application, the market has been classified as hip Fracture, hip
dislocation, osteoarthritis, and congenital dysplasia of the hip.
On the
basis of age group, the market has been classified as 4 to 6 years, 6 to 11
years, 12 to 19 years, and others.
On the
basis of end-users, the market has been classified as hospitals, clinics,
ambulatory surgical centers, and others.
On the
basis of region, the market is segmented into the Americas, Europe,
Asia-Pacific, and the Middle East and Africa. The Americas has been further
segmented into North America and South America, with the North American market
divided into the US and Canada.
The
European legg-calve-Perthes disease treatment market has been segmented into
Western Europe and Eastern Europe. Western Europe has further been classified
as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The
legg-calve-Perthes disease treatment market in Asia-Pacific has been segmented
into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The legg-calve-Perthes disease treatment market in the Middle East and Africa
has been segmented into the Middle East and Africa.
Regional
Market Summary
Global
Legg-Calve-Perthes Disease Treatment Share, by Region, 2017 (%)
Source:
MRFR Analysis
In the
legg-calve-Perthes disease treatment market, North America is anticipated to
account for the largest market share due to the early adoption of advanced
medical technologies, the rise in awareness, the rise in growth of the
healthcare sector, and also due to the rise in frequency of osteoarthritis.
The
European market is expected to hold the second largest market share. The market
growth in this region can be attributed to government funding and support from
the healthcare sector coupled with increasing research and development.
The
market share in Asia-Pacific is also projected to experience growth in the near
future due to access to optimal treatment facilities and growing demand for
advanced technology, better adoption rate, increase in disposable income, and
rising medical tourism.
The
market in the Middle East and Africa is expected to account for the smallest
share of the global legg-calve-Perthes disease treatment market due to an
underdeveloped healthcare sector, lack of technical knowledge, and poor medical
facilities.
Key
Players
Some of
the key players in the global legg-calve-Perthes disease treatment market are
BASF, Albemarle, Sunline, IOLCP, Shandong Xinhua Pharmaceutical Co. Ltd, Dr.
Reddy's, DePuy Synthes, Prime Medical, Zimmer, Biomet Holdings, Inc., 3M
Healthcare, Össur Hf, DJO, and Stryker Corporation.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment